Advertisement

Topics

X4 Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference

08:00 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
X4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 inhibitor drugs to improve immune cell trafficking to treat cancer and rare disease, today announced that Paula Ragan, PhD, President and C...

Other Sources for this Article

Media:
The Yates Network
Kathryn Morris, 845-635-9828
kathryn@theyatesnetwork.com
or
Investors:
Argot Partners
Melissa Forst, 212-600-1902
melissa@argotpartners.com

NEXT ARTICLE

More From BioPortfolio on "X4 Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...